Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$IQST - iQSTEL is a rising company with clear ambitions of becoming an international success. At one time, the company traded internationally through an innovative trading app, and its stock reached a price of $2 per share due to increasing interest from investors in the UK and other European countries. However, when that broker stopped trading OTC stocks, iQSTEL saw a sharp decline in daily trading volume. If iQSTEL can find some way to tap into this pool of international investors once again and reach out to buyers in the UK and beyond, iQSTEL has the potential to reach new heights in terms of market valuation and profitability. With over $90M in revenue and steadily growing business operations, iQSTEL is well-positioned for future growth and success.
https://finance.yahoo.com/quote/IQST/press-releases?p=IQST
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL. The dual listing will also build shareholder value and liquidity by making iQSTEL investment available to a broader range of global investors trading with a broader range of investment tools including USDC digital currency, credit, debit, PayPal, and USD. These tools will also be available to exist iQSTEL shareholders who signup for an Upstream account.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL. The dual listing will also build shareholder value and liquidity by making iQSTEL investment available to a broader range of global investors trading with a broader range of investment tools including USDC digital currency, credit, debit, PayPal, and USD. These tools will also be available to exist iQSTEL shareholders who signup for an Upstream account.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL. The dual listing will also build shareholder value and liquidity by making iQSTEL investment available to a broader range of global investors trading with a broader range of investment tools including USDC digital currency, credit, debit, PayPal, and USD. These tools will also be available to exist iQSTEL shareholders who signup for an Upstream account.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$MLRT - MetAlert, Inc. is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution that includes hardware software connectivity all designed for seamless integration into consumer products as well enterprise applications with two-way GPS technology which enables subscribers to track people or high-value assets anywhere on earth via the miniaturized low-power consumption components enabled by the latest RF NFC BLE tech allowing them to monitor exactly where their loved ones are at any given time. With its cutting-edge technology and strong industry partnerships, MetAlert is a great stock for investors who are looking for long-term growth potential.
https://pubcoinsight.com/the-seven-best-performing-stocks-to-own-for-the-long-term/
$MLRT - MetAlert is a Los Angeles-based company focusing on consumer healthcare and medical technology products. Its flagship GPS SmartSole tracker is the perfect solution for the problem of wandering because it was made specifically for this purpose. The SmartSole is an insole for shoes that comes equipped with a GPS and cellular tracking device built into it. It is easy to conceal, and patients are less likely to forget their boots at home before they head out the door. This flagship product is a significant catalyst for growth for the company! It's better to do DD on $MLRT.
https://ritzherald.com/why-this-otc-company-has-a-better-solution-than-apples-air-tags/
$MLRT - MetAlert, Inc. is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution that includes hardware software connectivity all designed for seamless integration into consumer products as well enterprise applications with two-way GPS technology which enables subscribers to track people or high-value assets anywhere on earth via the miniaturized low-power consumption components enabled by the latest RF NFC BLE tech allowing them to monitor exactly where their loved ones are at any given time. With its cutting-edge technology and strong industry partnerships, MetAlert is a great stock for investors who are looking for long-term growth potential.
https://pubcoinsight.com/the-seven-best-performing-stocks-to-own-for-the-long-term/
I got a major stock tip. Take a look at this. Precision Genomics is a key actor in precision medicine and medical AI. Precision Genomics, founded by prominent scientists who have successfully taken firms public on major stock markets, uses cutting-edge mRNA technology and machine learning algorithms to create breakthrough therapies for ailments such as cancer and heart disease. This ground-breaking finding might be one of the most significant advances in modern medicine, making Precision Genomics a hot stock for investors. And, with reports that the firm would shortly announce an IPO on the NASDAQ, now may be the ideal time to seize this chance. So if you're looking for an undiscovered gem in today's volatile markets, look no further than Precision Genomics - $LUDG.
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$LUDG - Precision Genomics is an exciting and innovative company that is at the forefront of major breakthroughs in the field of medical technology. Founded by top scientists with experience taking companies to NASDAQ and NYSE, Precision Genomics uses cutting-edge mRNA technology and machine-learning algorithms to diagnose and treat diseases like cancer and heart disease. This discovery has the potential to be one of the biggest medical advancements in recent years, with major implications for the way we approach disease prevention and treatment. And even better, it looks as though Precision Genomics may soon be planning a mini IPO, which could make this stock a true "undiscovered gem" on the trading market. Whether you're an investor considering adding this company to your portfolio, or simply someone interested in staying up-to-date on major trends in healthcare tech, Precision Genomics is a stock you won't want to miss out on.
https://finance.yahoo.com/quote/LUDG/community?p=LUDG
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$CLIS - ClickStream Corp. has begun the adoption of Polygon/MATIC to lower transaction costs for the minting of NFTs and extend the usefulness beyond just art. Adopting Polygon allows Nifter™ to use NFTs as events tickets, memorabilia trade-ins, content royalty tracking, and other revenue streams that are a part of Nifter's revenue strategy.
https://finance.yahoo.com/news/nifter-begins-cross-chain-adoption-123800904.html
$CLIS - ClickStream Corp. has begun the adoption of Polygon/MATIC to lower transaction costs for the minting of NFTs and extend the usefulness beyond just art. Adopting Polygon allows Nifter™ to use NFTs as events tickets, memorabilia trade-ins, content royalty tracking, and other revenue streams that are a part of Nifter's revenue strategy.
https://finance.yahoo.com/news/nifter-begins-cross-chain-adoption-123800904.html
$CLIS - ClickStream Corp. has begun the adoption of Polygon/MATIC to lower transaction costs for the minting of NFTs and extend the usefulness beyond just art. Adopting Polygon allows Nifter™ to use NFTs as events tickets, memorabilia trade-ins, content royalty tracking, and other revenue streams that are a part of Nifter's revenue strategy.
https://finance.yahoo.com/news/nifter-begins-cross-chain-adoption-123800904.html
$SFLM - SFLMaven recently announced the launch of its second line of NFTs in the Decentraland Metaverse. It is also working on developing a new novel technology that displays the value of an NFT along with the avatar in any Metaverse environment. SLFMaven started as a vintage jewelry store on eBay that still does over $1 million in sales each month. SFLMaven’s next line of NFTs is believed to be launching in Decentraland in the new year.
https://pubcoinsight.com/moncler-is-the-latest-fashion-brand-to-join-the-metaverse
$SFLM - SFLMaven recently announced the launch of its second line of NFTs in the Decentraland Metaverse. It is also working on developing a new novel technology that displays the value of an NFT along with the avatar in any Metaverse environment. SLFMaven started as a vintage jewelry store on eBay that still does over $1 million in sales each month. SFLMaven’s next line of NFTs is believed to be launching in Decentraland in the new year.
https://pubcoinsight.com/moncler-is-the-latest-fashion-brand-to-join-the-metaverse
$SFLM - SFLMaven is introducing some innovative new ideas. It is dropping its second NFT line in early 2023 and is looking into creating a novel technology that would display NFT values with avatars in the Decentraland environment. SFLMaven is no longer just a luxury jewelry seller on eBay and is establishing itself as one of the new leaders in the Metaverse for the future.
https://pubcoinsight.com/metaverse-stocks-28/
CEO Patrick Bertagna of $MLRT - MetAlert discussing the Company's New Image.
CEO Patrick Bertagna of MetAlert discussing the Company's New Image.
CEO Patrick Bertagna of MetAlert discussing the Company's New Image.
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$EDXC - Endexx Corp. has secured a new $3.8 million USD order for its newly acquired, non-nicotine-based vape product, HYLA from customers in Italy.
This $3.8M order is significant in two ways for Endexx. First, it provides the Company with more than $6M of revenue in its first two fiscal quarters of 2023, significantly surpassing its revenue for the entirety of the previous fiscal year. Given that the order came from customers in Italy, it is expected that this influential market will also expand the Company’s footprint in regions to the east, where it is believed that in addition to providing a geographic connection, Italy is considered very influential from both an economic and cultural perspective.
https://finance.yahoo.com/news/endexx-secures-3-8m-order-120000642.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$LUDG - Precision Genomics, a Ludwig subsidiary, is an innovative company whose mission is to help people live longer, healthier lives. The company is working diligently to prepare and file an S-1 with the SEC, with the ultimate goal of achieving a listing on NASDAQ. A patent has been filed while the company's research program continues in the hope of delivering potentially life-saving information straight into customers' hands. This is a totally off-the-radar stock. Highly recommend everybody pick up a few shares before it becomes a public name!
https://finance.yahoo.com/news/precision-genomics-successfully-attends-ld-120000524.html
$IQST - iQSTEL is a rising company with clear ambitions of becoming an international success. At one time, the company traded internationally through an innovative trading app, and its stock reached a price of $2 per share due to increasing interest from investors in the UK and other European countries. However, when that broker stopped trading OTC stocks, iQSTEL saw a sharp decline in daily trading volume. If iQSTEL can find some way to tap into this pool of international investors once again and reach out to buyers in the UK and beyond, iQSTEL has the potential to reach new heights in terms of market valuation and profitability. With over $90M in revenue and steadily growing business operations, iQSTEL is well-positioned for future growth and success.
https://finance.yahoo.com/quote/IQST/press-releases?p=IQST
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$IQST - iQSTEL has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex ("Horizon") and MERJ Exchange Limited ("MERJ").
The planned dual listing on Upstream is designed to provide iQSTEL the opportunity to access a global, digital-first investor base that can trade using USDC digital currency along with a credit, debit, PayPal, and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in OTCQX-quoted iQSTEL.
https://www.globenewswire.com/news-release/2022/11/07/2549642/0/en/IQST-iQSTEL-Announces-Application-for-Dual-Listing-on-Upstream.html
$MLRT - MetAlert is a Los Angeles-based company focusing on consumer healthcare and medical technology products. Its flagship GPS SmartSole tracker is the perfect solution for the problem of wandering because it was made specifically for this purpose. The SmartSole is an insole for shoes that comes equipped with a GPS and cellular tracking device built into it. It is easy to conceal, and patients are less likely to forget their boots at home before they head out the door. This flagship product is a significant catalyst for growth for the company! It's better to do DD on $MLRT.
https://ritzherald.com/why-this-otc-company-has-a-better-solution-than-apples-air-tags/
$MLRT - MetAlert, Inc. is a pioneer in smart, mobile, and wearable tracking and recovery location-based solutions, supported through a proprietary IoT enterprise monitoring platform and intellectual property portfolio. The company offers a global end-to-end solution that includes hardware software connectivity all designed for seamless integration into consumer products as well enterprise applications with two-way GPS technology which enables subscribers to track people or high-value assets anywhere on earth via the miniaturized low-power consumption components enabled by the latest RF NFC BLE tech allowing them to monitor exactly where their loved ones are at any given time. With its cutting-edge technology and strong industry partnerships, MetAlert is a great stock for investors who are looking for long-term growth potential.
https://pubcoinsight.com/the-seven-best-performing-stocks-to-own-for-the-long-term/